Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.

In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.

Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.

Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells.

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.

Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants.

Calcium transport and regulation in human primary and metastatic melanoma.

Cyclic AMP (cAMP) signaling in melanocytes and melanoma.

Crosstalk in skin: melanocytes, keratinocytes, stem cells, and melanoma.

Metastatic melanoma and immunotherapy.

Myositis and metastatic melanoma.

Protective effect of madecassoside on H2O2-induced oxidative stress and autophagy activation in human melanocytes.

Ribonucleotide diphosphate reductase from human metastatic melanoma.

Comparison of c-Kit expression between primary and metastatic melanoma of skin and mucosa.

An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia.

Effects of diethylstilbestrol on the proliferation and tyrosinase activity of cultured human melanocytes.

Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.

Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas.

Heat shock induces the transcriptional activation of c-fos protooncogene.

Epigenetic impacts of ascorbate on human metastatic melanoma cells.

Cellular and molecular biology of melanoma.

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

Cellular morphology of human malignant melanoma in primary culture.

BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression.

Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma.

Suggest Documents

In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.

Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.

Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells.

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.

Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants.

Calcium transport and regulation in human primary and metastatic melanoma.

Cyclic AMP (cAMP) signaling in melanocytes and melanoma.

Crosstalk in skin: melanocytes, keratinocytes, stem cells, and melanoma.

Metastatic melanoma and immunotherapy.

Myositis and metastatic melanoma.

Protective effect of madecassoside on H2O2-induced oxidative stress and autophagy activation in human melanocytes.

Ribonucleotide diphosphate reductase from human metastatic melanoma.

Comparison of c-Kit expression between primary and metastatic melanoma of skin and mucosa.

An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia.

Effects of diethylstilbestrol on the proliferation and tyrosinase activity of cultured human melanocytes.

Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.

Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas.

Heat shock induces the transcriptional activation of c-fos protooncogene.

Epigenetic impacts of ascorbate on human metastatic melanoma cells.

Cellular and molecular biology of melanoma.

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

Cellular morphology of human malignant melanoma in primary culture.

BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression.

Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma.

Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.

Recommend Documents

Follow Us